DAPAHENZ 5 15

About

Dapagliflozin 5mg is an oral medication belonging to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors, primarily used in the management of type 2 diabetes mellitus. It exerts its therapeutic effect by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine and a subsequent reduction in blood sugar levels. This unique insulin-independent mechanism helps to improve glycemic control.

Beyond its glucose-lowering effects, dapagliflozin has demonstrated significant benefits in reducing the risk of cardiovascular events, such as cardiovascular death and hospitalization for heart failure, in patients with type 2 diabetes and established cardiovascular disease or multiple risk factors. Furthermore, it plays a crucial role in slowing the progression of chronic kidney disease, making it a multifaceted treatment option that addresses several critical aspects of patient health.

Uses

• Treatment of type 2 diabetes mellitus.
• To reduce the risk of cardiovascular death.
• To reduce the risk of hospitalization for heart failure.
• To slow the progression of chronic kidney disease.

Directions For Use

Take orally once daily in the morning, with or without food.

Benefits

• Effectively lowers blood glucose.
• Promotes modest weight loss.
• Reduces blood pressure.
• Provides cardiovascular protection.
• Offers renal protective effects.
• Lowers HbA1c levels.

Side Effects

• Genital yeast infections.
• Urinary tract infections.
• Increased urination.
• Thirst.
• Dizziness.
• Low blood pressure (hypotension).
• Ketoacidosis (rare).
• Kidney problems.
• Fournier's gangrene (very rare).
• Bone fractures.
• Hypoglycemia (when combined with insulin/sulfonylureas).
• Dehydration.

Safety Measures

• Alcohol - Limit alcohol intake as it can increase the risk of dehydration and, rarely, ketoacidosis.
• Pregnancy - Not recommended during the second and third trimesters due to potential adverse effects on fetal kidney development.
• Breastfeeding - Avoid use while breastfeeding as it is unknown if dapagliflozin is excreted in human milk.
• Liver - Use with caution in patients with severe hepatic impairment; close monitoring is advised.
• Kidney - Dose adjustment or contraindication may be necessary in patients with severe renal impairment.
• Lung - Generally safe for use in patients with lung conditions; no specific contraindications are noted.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.